Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Online community where HCPs and researchers access the latest breakthroughs in medicine and life sciences research.
      
      Gain Free Access
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Medical Device
  - Payors
  - Research & Science
  - Providers
- - Featured
  - - Introducing GenosAI™
      
      Seamlessly embedded in H1’s Trial Landscape platform, GenosAI provides a chatGPT experience to help simplify complex queries, accelerate PI/Site section, and revolutionize clinical trial design.
      
      Learn More
Resources
Company
- - What’s New
  - Press
  - Featured Press
  - - H1 Boosts Flagship Clinical Trial Intelligence Platform with Generative AI to Accelerate Clinical Trials
      
      Learn More
- - Get in Touch
  - Contact Us
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor listening to patient's heart

Optimizing Clinical Data Registries: Opportunities for Diversity and Feasibility

In an October 2023 report, BMC Medicine completed a follow-up on a 10-year effort to understand, report on and track data sharing challenges with big pharma, specifically for clinical… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

KOL Engagement

Medical Devices

Provider Data

Research

Post Industries:

Commercialization

Medical Devices

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

Artificial Intelligence
AI for Hire: 5 Considerations for AI Innovation Workforce Strategies
At every industry conference this fall, half of the sessions will likely be focused on artificial intelligence (AI) and how important it is. The challenge is in knowing how AI… Continue reading →

Read the article
no
Artificial Intelligence
The Technology Conundrum
“Technology is a tool. How it’s applied is up to us.” – Wendell Wallach As human beings, our daily decisions impact the lives of others. To guide these decisions,… Continue reading →

Read the article
no
Artificial Intelligence
The Power of Data: Three Ways to Rethink AI Hallucinations
In this new content series, H1’s Senior Director of Strategic Commercial Engagement, Robert Consalvo, writes about leveraging generative AI for business, digital health, life sciences, biotech and pharma and the… Continue reading →

Read the article
no
Artificial Intelligence
Balancing Creativity and Accuracy in Artificial Intelligence
In the realm of AI, balancing creativity and accuracy is a critical consideration, especially when developing AI systems for business applications. While creativity adds novelty and innovation to outputs,… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Medical Devices Provider Data Research
H1 Honored with a Spot on Y Combinator’s 2023 Best Companies List and Slice of Healthcare’s Inaugural Digital Health Leaders List
H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced that it has been recognized in two prestigious annual lists: Y Combinator’s 2023 Best Companies… Continue reading →

Read the article
no
Research
Research Collection: Breast Cancer
Our series of Faculty Opinions Essential Reading collections continues with a focus this time on Breast Cancer research. Breast cancer is the most commonly diagnosed cancer worldwide, with a new… Continue reading →

Read the article
Research
The COVID-19 Essential Reading Collection
The next collection in our series of Faculty Opinions Essential Reading that we want to highlight is COVID-19. When the COVID-19 pandemic arrived, it disrupted nearly every aspect of our… Continue reading →

Read the article
Research
Research Collection: Alzheimer’s Disease
We’re delighted to launch the second Faculty Opinions Essential Reading collection: Alzheimer’s. Millions of people worldwide live with dementia, including Alzheimer’s. Our Faculty finds and assesses the literature to highlight the… Continue reading →

Read the article
Research
Research Collection: Opioid Addiction
We’re delighted to launch the fourth Faculty Opinions Essential Reading collection: Opioid Addiction. “Opioid abuse and addiction are major global health issues today. This collection aims to collate notable research… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Medical Devices Provider Data Research
New Look, Same Commitment!
I’m excited to officially unveil the new branding and website our team has been working on for several months. This new branding comes with much thought and consideration, and reflects… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Medical Devices Provider Data Research
Timmy Awards Announces H1 as 2022 Tech for Good Finalist
The 8th Annual Timmy Awards run by Tech in Motion celebrates leaders in tech, recognizing the top workplaces for tech professionals across North America. We are thrilled to announce that H1 is… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
The Evolution of H1’s Core Values
I remember it clearly. Me, Ian – our co-founder and a handful of brave individuals who would become the first H1 employees, sitting around a table writing down the values… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Recognized as One of Forbes’ Best Startup Employers 2022
H1, which provides the largest global healthcare professional data ecosystem to enable life sciences, academic medical institutions, health systems, and payers, today announced it has been included on Forbes’… Continue reading →

Read the article
Research
H1 Acquires Faculty Opinions, Enhances Impact
When I started H1, I had one purpose in mind: to create a healthier future. With that goal at the forefront, the immediate follow-up question becomes “How?”. We do… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Named to NYC Digital Health 100 by NYCHBL
H1, which provides the largest global healthcare platform that connects healthcare professionals, today announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Wraps Up 2021 with Gratitude
2021 was a year of enormous change around the world, as we learn to live and work in new ways. For H1, it was also a year of enormous growth,… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Co-Founder and CEO of H1 Named to Forbes 30 Under 30
H1 announced today that its CEO and Co-Founder Ariel Katz was named to the prestigious Forbes 30 under 30 list. Ariel started his first company in college, ResearchConnection, to help… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Ziad Ismail Joins H1 During Period of High Growth
H1, which provides the largest global healthcare network that connects healthcare professionals, announced today that it has added Ziad Ismail to the management team as Chief Operating Officer. Ziad… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Raises Series C
Today we announced our Series C of $100 million led by Altimeter and participation from new investors including Goldman Sachs Asset Management and Flex Capital. It also includes the support… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Former Dropbox CIO Joins Board of Healthcare Data Startup H1
Board member Sylvie Veilleux (Salesforce, Dropbox), CFO Karen Moran (Alteryx, Domo) and CDO Mayur Thakur (Goldman Sachs, Google) bring decades of experience and add bench strength as H1 expands.… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Closes $58 Million Series B Funding
Today, H1 announced a $58 million Series B round of funding to continue working towards our mission of creating a healthier future by connecting parties in the healthcare ecosystem.… Continue reading →

Read the article

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
Carevoyance
H1 Connect

About

About H1
Culture
Press
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2023 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape
Carevoyance

Don't have an account? Request a demo.

✕

Volunteer to provide emergency medical services in Israel, West Bank & Gaza. Learn more.